Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+15.82%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$28.7B
AUM Growth
+$4.18B
(+17%)
Cap. Flow
-$12.2B
Cap. Flow
% of AUM
-42.5%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
1,665
New
77
Increased
1,004
Reduced
446
Closed
86
Top Buys
| 1 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$69.1M |
| 2 |
iShares S&P 100 ETF
OEF
|
$58.9M |
| 3 |
iShares MBS ETF
MBB
|
$58.1M |
| 4 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
$58.1M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$34.2M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$4.12B |
| 2 |
MakeMyTrip
MMYT
|
$2.34B |
| 3 |
Trip.com Group
TCOM
|
$752M |
| 4 |
Yum China
YUMC
|
$508M |
| 5 |
Alibaba
BABA
|
$457M |
Sector Composition
| 1 | Technology | 34.56% |
| 2 | Communication Services | 9.63% |
| 3 | Consumer Discretionary | 9.36% |
| 4 | Healthcare | 6.11% |
| 5 | Financials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Tyra Biosciences
TYRA
$674M
| $19.7K | ﹤0.01% |
2,054
+361
| +21% | +$3.46K |
|
1402
Sezzle
SEZL
$2.92B
| $19.4K | ﹤0.01% |
108
-3,660
| -97% | -$656K |
|
1403
Kura Oncology
KURA
$713M
| $19.3K | ﹤0.01% |
3,344
+642
| +24% | +$3.7K |
|
|
MESO
1404
Mesoblast
MESO
$1.84B
| $19.1K | ﹤0.01% |
1,755
+617
| +54% | +$6.72K |
|
1405
MindMed
MNMD
$702M
| $18.9K | ﹤0.01% |
2,919
+465
| +19% | +$3.02K |
|
|
AMED
1406
DELISTED
Amedisys
AMED
| $18.9K | ﹤0.01% |
192
-11
| -5% | -$1.08K |
|
|
DEA
1407
Easterly Government Properties
DEA
$1.05B
| $18.9K | ﹤0.01% |
850
-235
| -22% | -$5.22K |
|
|
PDM
1408
Piedmont Realty Trust, Inc.
PDM
$1.09B
| $18.8K | ﹤0.01% |
2,577
-772
| -23% | -$5.63K |
|
1409
Zevra Therapeutics
ZVRA
$502M
| $18.6K | ﹤0.01% |
2,112
+326
| +18% | +$2.87K |
|
1410
Saia
SAIA
$8.34B
| $18.4K | ﹤0.01% |
67
+1
| +2% | +$274 |
|
1411
Zeekr
ZK
$7.43B
| $18.3K | ﹤0.01% |
717
+77
| +12% | +$1.96K |
|
1412
HUTCHMED
HCM
$2.74B
| $18K | ﹤0.01% |
1,198
+160
| +15% | +$2.41K |
|
1413
SIGA Technologies
SIGA
$603M
| $18K | ﹤0.01% |
2,760
+371
| +16% | +$2.42K |
|
|
AUTL
1414
Autolus Therapeutics
AUTL
$389M
| $17.7K | ﹤0.01% |
7,746
+1,956
| +34% | +$4.46K |
|
1415
Marathon Digital Holdings
MARA
$5.63B
| $17.5K | ﹤0.01% |
1,115
-11,708
| -91% | -$184K |
|
1416
Fortrea Holdings
FTRE
$1.06B
| $17.3K | ﹤0.01% |
3,496
+653
| +23% | +$3.23K |
|
1417
Cullinan Oncology
CGEM
$413M
| $17.2K | ﹤0.01% |
2,280
+306
| +16% | +$2.3K |
|
|
SNDK
1418
Sandisk Corporation Common Stock
SNDK
$9.99B
| $16.6K | ﹤0.01% |
365
+79
| +28% | +$3.58K |
|
1419
iRobot
IRBT
$102M
| $16.4K | ﹤0.01% |
5,254
+360
| +7% | +$1.13K |
|
1420
Gaotu Techedu
GOTU
$877M
| $16.2K | ﹤0.01% |
+4,500
| New | +$16.2K |
|
|
ORKA
1421
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
| $16.2K | ﹤0.01% |
1,446
+193
| +15% | +$2.16K |
|
1422
Precigen
PGEN
$1.3B
| $16.2K | ﹤0.01% |
11,403
+1,603
| +16% | +$2.28K |
|
1423
Core Scientific
CORZ
$4.16B
| $16.2K | ﹤0.01% |
948
-5,916
| -86% | -$101K |
|
|
RAPP
1424
Rapport Therapeutics
RAPP
$524M
| $16K | ﹤0.01% |
1,410
+144
| +11% | +$1.64K |
|
1425
Unity
U
$18.5B
| $16K | ﹤0.01% |
662
-89,404
| -99% | -$2.16M |
|